Ekso Bionics Stock (NASDAQ:EKSO)


ForecastChart

Previous Close

$0.40

52W Range

$0.37 - $1.57

50D Avg

$0.60

200D Avg

$0.91

Market Cap

$9.58M

Avg Vol (3M)

$1.18M

Beta

1.43

Div Yield

-

EKSO Company Profile


Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

70

IPO Date

Jan 17, 2014

Website

EKSO Performance


Latest Earnings Call Transcripts


Q2 22Jul 28, 22 | 7:53 PM
Q4 21Feb 24, 22 | 11:06 PM
Q3 21Nov 02, 21 | 10:20 PM

Peer Comparison


TickerCompany
LMATLeMaitre Vascular, Inc.
PDEXPro-Dex, Inc.
ATRIAtrion Corporation
UTMDUtah Medical Products, Inc.
NEPHNephros, Inc.